Modernizing Biosafety (IBC) Regulations

Modernizing Biosafety (IBC) Regulations On September 9, the NIH announced plans to modernize their biosafety regulatory framework. You can see details here: https://www.nih.gov/about-nih/nih-director/statements/nih-launches-initiative-modernize-strengthen-biosafety-oversight and here: https://osp.od.nih.gov/policies/biosafety-and-biosecurity-policy/#tab2/ The NIH has indicated the new regulations will align with risk, lower regulatory burden for low-risk research, expand oversight beyond work with recombinant and synthetic nucleic acids, and empower IBCs. […]

Read More

Upcoming Holidays and the IRB

Please plan for a little extra time during the upcoming holiday season for application approvals, as some of our meetings will be canceled; see schedule below. November 26, 2025 (day before Thanksgiving): Regular IRB board meeting December 24, 2025 (Christmas Eve): Canceled board meeting December 31, 2025 (New Year’s Eve): Canceled board meeting January 7, […]

Read More

New IRB Guidance, MRI Risk Language

New IRB Guidance We are excited to share two new guidance pages designed to help you understand when IRB review is required and when a project may be Non-Human Subjects Research (NHSR). These resources provide more information about projects that may not need to be reviewed by the IRB. These resources intended to provide you […]

Read More

Urgent Update: Temporary Halt on Debit Card Distribution for Human Research Participant Payments

The Clinical Research Support Office is aware of escalating fraudulent activity impacting participant debit cards and the significant burden this could place on your participants to submit fraud claims to the Hyperwallet Visa team. It is unacceptable that some participants are receiving cards with depleted funds due to this activity. We understand that replacement cards […]

Read More